GLAXF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline PLC

Watchlist Manager

Watchlist

Price: 25.76 USD -1.79%

Market Cap: $105.1B

G	GlaxoSmithKline PLC OTC:GLAXF	UK
V	Vext Science Inc CNSX:VEXT	CA
	Sumitomo Chemical Co Ltd OTC:SOMMF	JP

Profitability Summary

GlaxoSmithKline PLC's profitability score is 66/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Gross Margin is Increasing

72% > 73%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 27%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

53% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

8% > 15%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

13% > 18%

View All

Hide

Collapse

66 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.